At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
Biatain Silicone Sacral dressingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Single-arm Study Investigating the Safety of Biatain Silicone Sacral While Used as Prevention in Hospital-admitted Patients at Risk of Developing a Pressure Injury
In Brief
A clinical study evaluating Biatain Silicone Sacral dressing for Pressure Injury Prevention. Completed, enrolled 67 participants across 3 sites.
Detailed Summary
A post market clinical follow-up study investigating the safety of Biatain Silicone Sacral while used as prevention in hospital admitted patients at risk of developing a pressure injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPressure Injury Prevention
CountriesDenmark
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartAug 2022
First PostedNov 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedNov 16, 2022
Enrollment StartAug 15, 2022
Primary CompletionDec 8, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.6 years ago
Interventions
Biatain Silicone Sacral dressingdevice
Biatain Silicone Sacral dressing will be applied over the bony prominence of the sacral area as part of a PIP (Pressure Injury Prevention) protocol in patients at risk